The American Diabetes Association (ADA) today announced that more than 1.3 million people will be eligible to take insulin with an electronic test within the next two weeks.
The ADA’s decision marks the first time that an ADA-regulated insulin test has been able to be used to help determine whether someone is diabetic.
It also gives patients a new way to monitor their insulin levels.
The test, which has been in use since January, helps users determine if they have type 2 diabetes, which affects about 2 million Americans.
The first test was released on January 8, the day after the first patient was diagnosed.
It was a trial of an insulin test that was first used by a group of diabetic patients in New York City.
The tests are available through the ADA’s Diabetes Care Network and online at the ADA website.
If the ADA test is approved for use by a health care provider, the device will be given to all eligible adults who are currently using insulin, including those who have type 1 diabetes.
The device also provides information about insulin use, including how much is left in the body.
Patients who take the test for the first period of time and are considered diabetic may still have a chance to take the next set of tests.
Those who test positive for diabetes in the first two months after being diagnosed can still use the test.
The ADA will continue to review whether additional tests will be needed for those who test negative.
The results of the new test can be compared with a person who has a normal glucose tolerance, which is defined as a body mass index (BMI) between 17 and 25.
The new test also has the ability to distinguish between Type 1 and Type 2 diabetes.
Type 1 diabetes affects about 9 million people, with more than 2 million people living with type 1.
Type 2 Diabetes affects about 5 million people with type 2.
The diabetes test also includes a blood glucose meter that can be used with other devices.
It is also the first test to include a portable glucose monitor, the ADA said.
A device called the glucose monitor can be placed on a belt near the hip or ankle, and it measures blood sugar levels in a portable device.
In addition to the new tests, the test will also include a new “quick glucose” test that allows users to check their blood sugar within seconds.
A person who tests negative and takes the quick glucose test can still take the “fast glucose” blood test.
Those with type-2 diabetes will be required to take another test at the same time.
The American Diabetes Research Foundation and the ADA announced a new partnership to improve the insulin testing experience.
The first of these tests is set to be released by the end of the year.
The Diabetes Care Connect program will help ensure that everyone with diabetes has access to the testing service.
The program also will offer training on how to use the new device and how to ensure that it is accessible.